Vievitra, MB - financials and debts

Company age: 1 y. 4 mo.

Update

Vievitra - Company finances

EUR
2025
From: 2025-06-19
To: 2025-12-31
Financial data
Sales revenue 31,550
Profit before tax 8,952
Net profit 8,952
Equity 15,451
Liabilities 6,154
Non-current assets 0
Current assets 21,605
Total assets 21,605
Taxes paid
STI taxes 1,734
Financial indicators
Revenue change y/y -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 41.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 57.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 28.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 28.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.4
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 31,550

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Vievitra - Social security debts

From To Debt, €
2026-06-08 2026-06-08 70.36
2025-09-09 2025-09-14 64.95
2025-09-08 2025-09-08 137.40
2025-09-07 2025-09-07 140.40
2025-09-02 2025-09-03 140.40
2025-08-31 2025-09-01 67.95
2025-08-19 2025-08-29 67.95
2025-08-06 2025-08-18 66.46
2025-08-02 2025-08-05 67.95
2025-08-01 2025-08-01 69.47

Vievitra - VMI tax arrears

From To Overdue, €
2026-02-21 2026-02-21 5.0
2026-01-18 2026-01-23 2.34
2026-01-17 2026-01-17 0.36
2026-01-09 2026-01-09 698.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.